Eiko LifeSciences received confirmation from its share transfer agent that no requests were made to convert physical shares into electronic form during the last quarter. This indicates a smooth operational process for share transfers and robust adherence to shareholder record-keeping requirements. For investors, this ensures transparency and proper management of electronic share holdings, reflecting standard compliance practices.